Search - tctmd.com

Displaying 561 - 580 of 627

Sort: Relevancy | Date

Presentation CTO 2012

Complex PCI: Left Main and CTO Summit

Presenter: J.F. Diaz

February 24, 2012

Presentation CTO 2012

Integrated Use of IVUS and FFR During Complex Left Main PCI With and Without Multivessel Disease (with Case Vignettes)

Presenter: Seung-Jung Park

February 23, 2012

News Daily News

Live Case Procedures Just as Safe as in Daily Practice

Caitlin E. Cox

February 21, 2012

News Daily News

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

L.A. McKeown

February 20, 2012

News Daily News

Younger Women with AMI Less Likely to Present with Chest Pain Than Men

Yael L. Maxwell

February 20, 2012

News Daily News

Paper Sparks Renewed Discussion on Appropriate Use of PCI

Yael L. Maxwell

February 08, 2012

Presentation TCT 2012

Contrast Induced Nephropathy in Patients With Normal Renal Function Undergoing Complex PCI with High Dose of Contrast Media : Predictive Value of Cystatin C

Presenter: Norbert Mayaud, Karl Isaaz, Christophe Mariat, Alexis Cerisier, Michel Lamaud, Laure Richard, Antoine Da Costa

January 03, 2012

News Daily News

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

December 04, 2011

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

News Conference News

PRISM Individualized Informed Consent Improves PCI Choice, Experience

November 14, 2011

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Industry News

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

November 10, 2011

News Conference News

PROTECT II: Positive Outcomes Observed with Impella Device

November 08, 2011

News Industry News

PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit the Most from Impella Support

November 08, 2011

News Conference News

SYNTAX at 4 Years: PCI and CABG Equivalent in Left Main Disease

November 07, 2011

News Industry News

Economic Study Demonstrates Cost-Effectiveness of Impella Presented at TCT 2011

November 07, 2011

News Conference News

Debate: PCI vs. CABG for Left Main Disease

November 07, 2011

News Daily News

Updated PCI, CABG Guidelines Highlight Interventional-Surgical Collaboration

November 06, 2011

News Industry News

Volcano Corporation Announces Upcoming Presentation of Late-Breaking Clinical Trial Results and FFR Product Launch at TCT 2011

November 04, 2011

News Daily News

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

L.A. McKeown

November 01, 2011

Advertisement

Complex PCI: Left Main and CTO Summit

Integrated Use of IVUS and FFR During Complex Left Main PCI With and Without Multivessel Disease (with Case Vignettes)

Live Case Procedures Just as Safe as in Daily Practice

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

Younger Women with AMI Less Likely to Present with Chest Pain Than Men

Paper Sparks Renewed Discussion on Appropriate Use of PCI

Contrast Induced Nephropathy in Patients With Normal Renal Function Undergoing Complex PCI with High Dose of Contrast Media : Predictive Value of Cystatin C

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

PRISM Individualized Informed Consent Improves PCI Choice, Experience

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

PROTECT II: Positive Outcomes Observed with Impella Device

PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit the Most from Impella Support

SYNTAX at 4 Years: PCI and CABG Equivalent in Left Main Disease

Economic Study Demonstrates Cost-Effectiveness of Impella Presented at TCT 2011

Debate: PCI vs. CABG for Left Main Disease

Updated PCI, CABG Guidelines Highlight Interventional-Surgical Collaboration

Volcano Corporation Announces Upcoming Presentation of Late-Breaking Clinical Trial Results and FFR Product Launch at TCT 2011

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content